A variety of consultant options are available to the pharma industry; this article is a 3-step guide to selecting the right consultant.
The pharmaceutical industry is one that relies heavily on consulting support across the product journey. From new drug application (NDA) to loss of exclusivity (LOE), commercialization consulting options are abundant, but sometimes finding the right consultant can be a challenge.
One of the benefits of decades of experience is knowing what good-and bad-looks like and learning how to align your needs and expectations with the expertise, experience, and capabilities of the right consultant for your project.
Having been on both sides of the consulting relationship-as the client and as the consultant-we’ve learned a few things about how to select a consulting partner that is the right fit, right now.
1. Look in the mirror. Deeply.
Finding the best consultant for your unique needs starts with you. It’s important to clearly define your goals and identify the strengths and weaknesses in your team, capabilities, and capacity to know where consulting help is most needed and exactly what type of consulting support you need.
Ask these questions internally before you begin to engage with prospective consulting groups:
2. Put the consultants under the microscope.
Once your introspective work is done, you should have a much better idea of what kind of consulting help you need. When evaluating potential consultants you’ll want to keep this in mind, but be sure to look just as deeply at how they approach their client engagements to ensure a great fit.
Based on how you answered the above, ask potential consulting partners the appropriate version of these questions:
3. Before making your decision, consider these general guidelines.
A large consulting practice with a global footprint and diverse service offering may be the best fit for you if:
A smaller, specialized, boutique consulting group may be the best fit for you if:
Selecting the right consultant can have an enormous impact on the success of your project. As the importance of your project rises, so should the level of attention paid to selecting the best partner. Taking time to follow these three steps will help you to have confidence in your consultant and ensure the success of your project.
Keith Bailey, Director, US New Products at Novartis
Douglas Bock, Partner at Archbow Consulting.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
FDA Approves AstraZeneca’s Calquence for Previously Untreated Mantle Cell Lymphoma
January 17th 2025Approval follows results from the Phase III ECHO trial, which demonstrated that Calquence plus chemotherapy reduced the risk of disease progression or death by 27% in patients with previously untreated mantle cell lymphoma.